Adult T-cell leukemia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Skazmi (talk | contribs)
Skazmi (talk | contribs)
Line 19: Line 19:


===Incidence===
===Incidence===
*  Among HTLV-1 carriers in high prevalence regions such as Central Australia, Japan and Carribean, adult T-cell leukemia/lymphoma (ATLL) will ultimately develop in 1%-5% of infected individuals.<ref name="pmid17376384">{{cite journal |vauthors=Verdonck K, González E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E |title=Human T-lymphotropic virus 1: recent knowledge about an ancient infection |journal=Lancet Infect Dis |volume=7 |issue=4 |pages=266–81 |date=April 2007 |pmid=17376384 |doi=10.1016/S1473-3099(07)70081-6 |url=}}</ref>
* In southern Japan, the age-adjusted incidence rate of adult T-cell leukemia is approximately 6.6 per 100,000 individuals.<ref name="pmid25219595">{{cite journal| author=Satake M, Yamada Y, Atogami S, Yamaguchi K| title=The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan. | journal=Leuk Lymphoma | year= 2015 | volume= 56 | issue= 6 | pages= 1806-12 | pmid=25219595 | doi=10.3109/10428194.2014.964700 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25219595  }} </ref><ref name="pmid22973265">{{cite journal| author=Iwanaga M, Watanabe T, Yamaguchi K| title=Adult T-cell leukemia: a review of epidemiological evidence. | journal=Front Microbiol | year= 2012 | volume= 3 | issue=  | pages= 322 | pmid=22973265 | doi=10.3389/fmicb.2012.00322 | pmc=PMC3437524 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22973265  }} </ref><ref name="wiki">Adult T-cell leukemia/lymphoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Adult_T-cell_leukemia/lymphoma Accessed on November, 3 2015</ref>
* In southern Japan, the age-adjusted incidence rate of adult T-cell leukemia is approximately 6.6 per 100,000 individuals.<ref name="pmid25219595">{{cite journal| author=Satake M, Yamada Y, Atogami S, Yamaguchi K| title=The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan. | journal=Leuk Lymphoma | year= 2015 | volume= 56 | issue= 6 | pages= 1806-12 | pmid=25219595 | doi=10.3109/10428194.2014.964700 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25219595  }} </ref><ref name="pmid22973265">{{cite journal| author=Iwanaga M, Watanabe T, Yamaguchi K| title=Adult T-cell leukemia: a review of epidemiological evidence. | journal=Front Microbiol | year= 2012 | volume= 3 | issue=  | pages= 322 | pmid=22973265 | doi=10.3389/fmicb.2012.00322 | pmc=PMC3437524 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22973265  }} </ref><ref name="wiki">Adult T-cell leukemia/lymphoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Adult_T-cell_leukemia/lymphoma Accessed on November, 3 2015</ref>



Revision as of 14:21, 9 May 2018

Adult T-cell leukemia Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adult T-cell leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray Findings

Echocardiography and Ultrasound

CT scan

MRI Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adult T-cell leukemia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adult T-cell leukemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adult T-cell leukemia epidemiology and demographics

CDC on Adult T-cell leukemia epidemiology and demographics

Adult T-cell leukemia epidemiology and demographics in the news

Blogs on Adult T-cell leukemia epidemiology and demographics

Directions to Hospitals Treating Adult T-cell leukemia

Risk calculators and risk factors for Adult T-cell leukemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

The majority of adult T-cell leukemia cases are reported in Japan, the Caribbean, South America, and Africa. In southern Japan, the age-adjusted incidence rate of adult T-cell leukemia is approximately 6.6 per 100,000 individuals. The incidence of adult T-cell leukemia increases with age; the median age at diagnosis is 57 years. Males are more commonly affected with adult T-cell leukemia than females. The male to female ratio is approximately 1.4 to 1. Adult T-cell leukemia usually affects individuals of the African American, Latin American, and Asian race. Caucasian individuals are less likely to develop adult T-cell leukemia.[1][2]

Epidemiology and Demographics

Prevalence

  • Human T-Lymphotropic Virus type 1 (HTLV-1) infects at least 5–10 million people worldwide.[3]
  • HTLV-1 is endemic to Central Australia and infection prevalence in this region ranges from a low of 7200 per 100,000 to a high of 13900 per 100,000 of socially disadvantaged indigenous adults.[4][5]
  • In the US, adult T-cell leukemia is considered a rare disease that mainly tends to develop among African American intravenous drug abusers.[6]
  • The majority of adult T-cell leukemia cases are reported in Japan, the Caribbean, South America, and Africa.
HTLV-1 prevalence in the North America, source: CDC
HTLV-1 prevalence in the Central and South America, source: CDC
HTLV-1 prevalence in the Australia and Oceania, source: CDC


Incidence

  •  Among HTLV-1 carriers in high prevalence regions such as Central Australia, Japan and Carribean, adult T-cell leukemia/lymphoma (ATLL) will ultimately develop in 1%-5% of infected individuals.[7]
  • In southern Japan, the age-adjusted incidence rate of adult T-cell leukemia is approximately 6.6 per 100,000 individuals.[1][2][8]
  • The annual incidence of adult T-cell leukemia development among HTLV-1 carriers is approximately 60 per 100,000 individuals.

Age

  • The incidence of adult T-cell leukemia increases with age; the median age at diagnosis is 57 years.[6]
  • The age of onset for adult T-cell leukemia differs across geographical regions, such as:
  • The median age at diagnosis in Japan is 60 years
  • The median age at diagnosis in Central America is 40 years

Gender

  • Males are more commonly affected with adult T-cell leukemia than females. The male to female ratio is approximately 1.4 to 1.[1][2][8]
  • Females are more commonly affected with HTLV infection than males.
  • However, the risk of adult T-cell leukemia development among HTLV male carriers is five fold higher than the risk of adult T-cell leukemia development among HTLV female carriers.

Race

  • Adult T-cell leukemia usually affects individuals of the African American, Latin American, and Asian race. Caucasian individuals are less likely to develop adult T-cell leukemia.[1][2][8]

References

  1. 1.0 1.1 1.2 1.3 Satake M, Yamada Y, Atogami S, Yamaguchi K (2015). "The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan". Leuk Lymphoma. 56 (6): 1806–12. doi:10.3109/10428194.2014.964700. PMID 25219595.
  2. 2.0 2.1 2.2 2.3 Iwanaga M, Watanabe T, Yamaguchi K (2012). "Adult T-cell leukemia: a review of epidemiological evidence". Front Microbiol. 3: 322. doi:10.3389/fmicb.2012.00322. PMC 3437524. PMID 22973265.
  3. "Clinical Associations of Human T-Lymphotropic Virus Type 1 Infection in an Indigenous Australian Population".
  4. Bastian I, Hinuma Y, Doherty RR (July 1993). "HTLV-I among Northern Territory aborigines". Med. J. Aust. 159 (1): 12–6. PMID 8316104.
  5. "Clinical Associations of Human T-Lymphotropic Virus Type 1 Infection in an Indigenous Australian Population".
  6. 6.0 6.1 Mahieux R, Gessain A (2007). "Adult T-cell leukemia/lymphoma and HTLV-1". Curr Hematol Malig Rep. 2 (4): 257–64. doi:10.1007/s11899-007-0035-x. PMID 20425378.
  7. Verdonck K, González E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E (April 2007). "Human T-lymphotropic virus 1: recent knowledge about an ancient infection". Lancet Infect Dis. 7 (4): 266–81. doi:10.1016/S1473-3099(07)70081-6. PMID 17376384.
  8. 8.0 8.1 8.2 Adult T-cell leukemia/lymphoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Adult_T-cell_leukemia/lymphoma Accessed on November, 3 2015

Template:WH Template:WS